These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33033718)

  • 1. High Speed AFM and NanoInfrared Spectroscopy Investigation of Aβ
    Feuillie C; Lambert E; Ewald M; Azouz M; Henry S; Marsaudon S; Cullin C; Lecomte S; Molinari M
    Front Mol Biosci; 2020; 7():571696. PubMed ID: 33033718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane domain modulation of Aβ
    Azouz M; Cullin C; Lecomte S; Lafleur M
    Nanoscale; 2019 Nov; 11(43):20857-20867. PubMed ID: 31657431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High speed atomic force microscopy to investigate the interactions between toxic Aβ
    Ewald M; Henry S; Lambert E; Feuillie C; Bobo C; Cullin C; Lecomte S; Molinari M
    Nanoscale; 2019 Apr; 11(15):7229-7238. PubMed ID: 30924478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipids uniquely alter the secondary structure and toxicity of amyloid beta 1-42 aggregates.
    Zhaliazka K; Matveyenka M; Kurouski D
    FEBS J; 2023 Jun; 290(12):3203-3220. PubMed ID: 36705524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in lipid membranes may trigger amyloid toxicity in Alzheimer's disease.
    Drolle E; Negoda A; Hammond K; Pavlov E; Leonenko Z
    PLoS One; 2017; 12(8):e0182194. PubMed ID: 28767712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of Aβ(1-42) amyloids with lipids promotes "off-pathway" oligomerization and membrane damage.
    Henry S; Vignaud H; Bobo C; Decossas M; Lambert O; Harte E; Alves ID; Cullin C; Lecomte S
    Biomacromolecules; 2015 Mar; 16(3):944-50. PubMed ID: 25689632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Amyloid peptide interactions with biomimetic membranes: A multiparametric characterization.
    Smeralda W; Since M; Cardin J; Corvaisier S; Lecomte S; Cullin C; Malzert-Fréon A
    Int J Biol Macromol; 2021 Jun; 181():769-777. PubMed ID: 33811932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of phosphatidylserine in amyloid-beta oligomerization at asymmetric phospholipid bilayers.
    Robinson J; Sarangi NK; Keyes TE
    Phys Chem Chem Phys; 2023 Mar; 25(11):7648-7661. PubMed ID: 36317678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.
    Michno W; Wehrli P; Meier SR; Sehlin D; Syvänen S; Zetterberg H; Blennow K; Hanrieder J
    J Neurochem; 2020 Mar; 152(5):602-616. PubMed ID: 31605538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallic acid disruption of Aβ
    Yu M; Chen X; Liu J; Ma Q; Zhuo Z; Chen H; Zhou L; Yang S; Zheng L; Ning C; Xu J; Gao T; Hou ST
    Neurobiol Dis; 2019 Apr; 124():67-80. PubMed ID: 30447302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aβ42 oligomers, but not fibrils, simultaneously bind to and cause damage to ganglioside-containing lipid membranes.
    Williams TL; Johnson BR; Urbanc B; Jenkins AT; Connell SD; Serpell LC
    Biochem J; 2011 Oct; 439(1):67-77. PubMed ID: 21702743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific domains of Aβ facilitate aggregation on and association with lipid bilayers.
    Yates EA; Owens SL; Lynch MF; Cucco EM; Umbaugh CS; Legleiter J
    J Mol Biol; 2013 Jun; 425(11):1915-1933. PubMed ID: 23524134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic toxic Aβ
    Bobo C; Chaignepain S; Henry S; Vignaud H; Améadan A; Marchal C; Prado E; Doutch J; Schmitter JM; Nardin C; Lecomte S; Cullin C
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1168-1176. PubMed ID: 28267577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of Alzheimer's peptide Aβ(1-40) oligomers and fibrils on supported lipid membranes.
    Canale C; Seghezza S; Vilasi S; Carrotta R; Bulone D; Diaspro A; San Biagio PL; Dante S
    Biophys Chem; 2013 Dec; 182():23-9. PubMed ID: 23998637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Insights for Alzheimer's Disease: An Unexplored Storyline on the Nanoscale Impact of Nascent Aβ
    Siniscalco D; Francius G; Tarek M; Bali SK; Laprévote O; Malaplate C; Oster T; Pauron L; Quilès F
    ACS Appl Mater Interfaces; 2023 Apr; 15(14):17507-17517. PubMed ID: 36995989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of the carboxyl terminus of the Alzheimer Abeta peptide on its conformation, aggregation, and neurotoxic properties.
    Soreghan B; Pike C; Kayed R; Tian W; Milton S; Cotman C; Glabe CG
    Neuromolecular Med; 2002; 1(1):81-94. PubMed ID: 12025818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atomic force microscopy to study molecular mechanisms of amyloid fibril formation and toxicity in Alzheimer's disease.
    Drolle E; Hane F; Lee B; Leonenko Z
    Drug Metab Rev; 2014 May; 46(2):207-23. PubMed ID: 24495298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
    Takahashi T; Mihara H
    Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloidogenicity and Cytotoxicity of a Recombinant C-Terminal His
    Jia L; Wang W; Sang J; Wei W; Zhao W; Lu F; Liu F
    ACS Chem Neurosci; 2019 Mar; 10(3):1251-1262. PubMed ID: 30537813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.